Neurol. praxi. 2021;22(2):132-138 | DOI: 10.36290/neu.2020.091
Current role of evoked potentials in multiple sclerosis diagnostics and monitoring
- Neurologická klinika FNKV a 3. LF UK, Praha
- Neurologické oddělení, Nemocnice Strakonice, a. s., Strakonice
Evoked Potentials (EP) represent relatively sensitive but less specific method in particular central nervous subsystems lesions diagnostics. Although the method does not bring additional value to prove Dissemination in Space (DIS), their indication might be helpful in multiple sclerosis (MS) patients. This article aims to provide an overview of commonly used EP modalities in the settings of MS (visual, somatosensory, motor, brain stem acoustic) regarding to the diagnostics and monitoring of disease course of particular MS forms. Somatosensory (SEP) and Motor (MEP) EP are the most sensitive methods in diagnostics of conduction abnormity relevant to MS due to the length of the pathways they measure. Evoked potentials seem to be the strongest predictor of disability in patients with primary progressive MS. Even though the current role of evoked potentials in MS diagnostics is massively replaced by magnetic resonance imaging. EP still remain a suitable method for prediction of disease course and novel drug trials monitoring.
Keywords: evoked potentials, multiple sclerosis, multimodal approach, prognosis.
Received: June 9, 2020; Revised: September 2, 2020; Accepted: September 3, 2020; Published: April 30, 2021 Show citation
References
- Aktas O, Wattjes MP, Stangel M, Hartung HP. Diagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017. Nervenarzt 2018; 89(12): 1344-1354.
Go to original source... 
Go to PubMed... - Barton JL, Garber JY, Klistorner A, Barnett MH. The electrophysiological assessment of visual function in Multiple Sclerosis. Clin Neurophysiol Pract 2019; 4: 90-96. Go to original source... Go to PubMed...
- Giffroy X, Maes N, Albert A, Maquet P, Crielaard JM, Dive D. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis? Acta Neurol Belg 2017; 117(1): 53-59. Go to original source... Go to PubMed...
- Hardmeier M, Leocani L, Fuhr P. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS. Mult Scler 2017; 23(10): 1309-1319. Go to original source... Go to PubMed...
- Iodice R, Carotenuto A, Dubbioso R, Cerillo I, Santoro L, Manganelli F. Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy. J Neurol Sci 2016; 365: 143-146. Go to original source... Go to PubMed...
- Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI. Functional clinical outcomes in multiple sclerosis: Current status and future prospects. Mult Scler Relat Disord 2015; 4(3): 192-201. Go to original source... Go to PubMed...
- Kimiskidis VK, Papaliagkas V, Sotirakoglou K, Kouvatsou ZK, Kapina VK, Papadaki E, Tsimourtou V, Masoura E, Kazis DA, Papayiannopoulos S, Geroukis T, Bostanjopoulou S. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings. Mult Scler Relat Disord 2016; 10: 192-197. Go to original source... Go to PubMed...
- Lascano AM, Lalive PH, Hardmeier M, Fuhr P, Seeck M. Clinical evoked potentials in neurology: a review of techniques and indications. Clinical evoked potentials in neurology: a review of techniques and indications. J Neurol Neurosurg Psychiatry 2017; 88(8): 688-696. Go to original source... Go to PubMed...
- Leocani L, Martinelli V, Natali-Sora MG, Rovaris M, Comi G. Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory tests. Mult Scler 2003; 9(3): 275-279. Go to original source... Go to PubMed...
- Leocani L, Guerrieri S, Comi G. Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis. J Neuroophthalmol 2018; 38(3): 350-357. Go to original source... Go to PubMed...
- London F, El Sankari S, van Pesch V. Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients. Clin Neurophysiol 2017; 128(4): 561-569. Go to original source... Go to PubMed...
- Humm AM, Z'Graggen WJ, Bühler R, Magistris MR, Rösler KM. Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone. J Neurol Neurosurg Psychiatry 2006; 77(3): 345-350. Go to original source... Go to PubMed...
- Margaritella N, Mendozzi L, Garegnani M, Nemni R, Colicino E, Gilardi E, Pugnetti L. Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS? BMC Neurol 2012; 12: 80. Go to original source... Go to PubMed...
- Margaritella N, Mendozzi L, Garegnani M, Nemni R, Gilardi E, Pugnetti L. The EP-score to assess treatment efficacy in RRMS patients: a preliminary study. Int J Neurosci 2015; 125(1): 38-42. Go to original source... Go to PubMed...
- Ntranos A, Lublin F. Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space. Curr Neurol Neurosci Rep 2016; 16(10): 90. Go to original source... Go to PubMed...
- Pelayo R, Montalban X, Minoves T, Moncho D, Rio J, Nos C, Tur C, Castillo J, Horga A, Comabella M, Perkal H, Rovira A, Tintoré M. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler 2010; 16(1): 55-61. Go to original source... Go to PubMed...
- Ramanathan S, Lenton K, Burke T, Gomes L, Storchenegger K, Yiannikas C, Vucic S. The utility of multimodal evoked potentials in multiple sclerosis prognostication. J Clin Neurosci 2013; 20(11): 1576-1581. Go to original source... Go to PubMed...
- Schlaeger R, D'Souza M, Schindler C, Grize L, Kappos L, Fuhr P. Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis. Mult Scler 2014a; 20(1): 51-56. Go to original source... Go to PubMed...
- Schlaeger R, D'Souza M, Schindler C, Grize L, Kappos L, Fuhr P. Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval? Clin Neurophysiol 2014b; 125(9): 1889-1892. Go to original source... Go to PubMed...
- Schlaeger R, Hardmeier M, D'Souza M, Grize L, Schindler C, Kappos L, Fuhr P. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems. Clin Neurophysiol 2016; 127(3): 1864-1871. Go to original source... Go to PubMed...
- Schlaeger R, Schindler C, Grize L, Dellas S, Radue EW, Kappos L, Fuhr P. Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years. Mult Scler 2014c; 20(10): 1348-1354. Go to original source... Go to PubMed...
- Snow NJ, Wadden KP, Chaves AR, Ploughman M. Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research. Neural Plast 2019; 2019: 6430596. Go to original source... Go to PubMed...
- Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-173. Go to original source... Go to PubMed...
- Zeller D, Reiners K, Bräuninger S, Buttmann M. Central motor conduction time may predict response to fampridine in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85(6): 707-709. Go to original source... Go to PubMed...
- Ziemann U, Wahl M, Hattingen E, Tumani H. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder. Prog Neurobiol 2011; 95(4): 670-685. Go to original source... Go to PubMed...